CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 37 filers reported holding CERULEAN PHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $755,000 | -49.7% | 721,145 | +1.8% | 0.02% | -54.5% |
| Q2 2016 | $1,501,000 | -24.1% | 708,215 | -3.0% | 0.06% | -23.6% |
| Q1 2016 | $1,978,000 | -7.6% | 730,015 | -4.5% | 0.07% | -2.7% |
| Q4 2015 | $2,140,000 | +55.0% | 764,375 | +102.6% | 0.07% | +72.1% |
| Q3 2015 | $1,381,000 | -9.6% | 377,277 | +13.6% | 0.04% | 0.0% |
| Q2 2015 | $1,528,000 | -11.5% | 332,225 | +73.3% | 0.04% | -12.2% |
| Q1 2015 | $1,727,000 | – | 191,705 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $8,909,000 | 8.51% |
| Polaris Venture Management Co IV LLC | 1,437,441 | $3,895,000 | 7.33% |
| Rock Springs Capital Management LP | 625,000 | $1,694,000 | 0.14% |
| Deer VII & Co. Ltd. | 166,675 | $452,000 | 0.12% |
| Granahan Investment Management | 730,015 | $1,978,000 | 0.07% |
| Northeast Financial Consultants Inc | 20,000 | $54,000 | 0.03% |
| Donald L. Hagan, LLC | 3,900 | $11,000 | 0.01% |
| Alyeska Investment Group, L.P. | 312,809 | $848,000 | 0.01% |
| WEDBUSH SECURITIES INC | 16,000 | $43,000 | 0.01% |
| TFS CAPITAL LLC | 15,895 | $43,000 | 0.01% |